期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

胰岛素泵治疗2型糖尿病中联用生长抑素的研究 被引量：1

Studay on short-term CS and somatostatin treatment on beta-cell function in newly diagnosised type 2 diabetic patients.
下载PDF
导出
摘要 目的观察短期胰岛素泵治疗新诊断2型糖尿病(T2DM)中联用生长抑素,患者β细胞恢复情况。方法自身前后对照8例新诊断T2DM并高血糖;短期1周胰岛素强化治疗,同时使用生长抑素。结果治疗后口服葡萄糖耐量试验(OGTT)出现明显增加的C肽曲线下面积。结论对伴高血糖的新诊断T2DM,胰岛素泵强化治疗1周同时使用生长抑素可以改善胰岛β细胞功能,缩短治疗时间。 Objective To investigate the effect of short - term CS and somatostatin treatment on beta - cell function in newly diagnosised type 2 diabetic petients. Methods 8 newly diagnose type 2 diabetic patients were treated with CS and somatostatin for one week. Results After one week treatment, the mean AUC of C - peplide was dramatically improved. Conclusion The excellent improrement of bete - cell function by Short - term CS and somatostatin treatment in newly diagnosised type 2 diabetic patients can improve the bete - cell function and shorten treat time.
作者 陈利强 王川 夏晓英
机构地区 惠州市中心医院内分泌科
出处 《临床和实验医学杂志》 2006年第6期691-692,共2页 Journal of Clinical and Experimental Medicine
关键词 2型糖尿痛 胰岛素泵 生长抑素 Type 2 diabetic CS Somatostatin
分类号 R587.1 [医药卫生—内分泌] R576 [医药卫生—消化系统]
  • 相关文献

参考文献5

二级参考文献22

  • 1Weyer. Dificiency in AIR predict IGT and Type 2 diabetes. Diabetes Care, 2001,24 : 89-94.
  • 2Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes, 1995,44: 1386-1391.
  • 3Bruce DG, Chisholm DJ, Leonare H, et al. Physiological importance of deficiency in early prandial insulin secretion in non-in-sulin-dependent diabetes. Diabetes, 1988,37: 736-743.
  • 4Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes, 1999,48: 99-105.
  • 5Ilkova H, glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
  • 6Walton C, Godsland IF, Proudler AJ, et al. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab,1992,75: 170-175.
  • 7Purrello F, Rabuazza AM. Metabolic factors that affect betacell function and survival. Diabet Nutr Metab, 2000, 13: 84-91.
  • 8Sivitz WI. Lipotoxieity and glueotoxieity in type 2 diabetes. Effects on development and progression. Postgrad Med, 2001,109: 55-59,63-64.
  • 9Lenhard M J, Reeves GD. Continous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med,2001,161: 2293-2300.
  • 10Dupuy O, Mayaudon H, Palou M, et al. Optimized transient insulin infusion in uneontrolled type 2 Diabetes : Evaluation of a pragmatie attitude. Diabet Med, 2000,26 : 371-375.

共引文献1371

同被引文献11

  • 1王昕,杨文英.胰高血糖素与糖尿病及其临床问题[J].实用糖尿病杂志,2006,2(5):3-5. 被引量：13
  • 2Zethelius B, Hales CN, Lithell HO, et al. Insulin resistance, mr- paired early insulin response, and insulin propeptides as predictors of the development of type 2 diabetes : a population-based, 7-year follow-up study in 70-year-old men [ J ]. Diabetes Care, 2004,27 (6) :1433-1438.
  • 3Basu R, Breda E, Oberg AL, et al. Mechanisms of the age-associ- ated deterioration in glucose tolerance:contribution of alterations in insulin secretion, action and clearance [ J ]. Diabetes, 2003,52 (7) :1738-1748.
  • 4Zamaklan M, JoticA, LalicN, et al. Relation between course of disease in type 1 diabetes and islet cell antibodies [ J ]. Ann N Y Acad Sci, 2002,958 (4) :251-253.
  • 5Carlsson A, Sundkvist G, Groop L, et al. Insulin and glueagon se- cretion in patients with slowly progressing autoimmune diabetes (LADA) [ Jl. J Clin Endoerinol Metab, 2000,85 ( 1 ) :76-80.
  • 6Larssan H, Ahren B. Glucose intolerance is predicted by low insu- lin secretion and high glucagon secretion:outcome of a prospective study in postmenopausal Caucasian women [ J]. Diabetologia, 2000,43 ( 2 ) : 194-202.
  • 7Henkel E, Menschikowski M, Koeblcr C, et al. Impact of gluca- gon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus [ J ]. Metabolism, 2005,54 (9) : 1168-1173.
  • 8Shah P, Basu A, Basu R, et al. Rizza Impact of lack of suppres- sion of glucagon on glucose tolerance in humans [ J ]. Physical, 1999,277 (2) :283-290.
  • 9Lewis T, Vranic M, Giacca A. Role of free fatty acids and gluca- gon in the peripheral effect of insulin on glucose production in hu- mans[J]. Physiol Endocrinol Metab, 1998,275( 1 ) :177-186.
  • 10Greenbaum C J, Prigeon RL, Alessio DA. Impaired-cell function, incretin effect, and glucagon suppression in patients with type 1 di- abetes who have normal fasting glucose [ J ]. Diabetes, 2002,51 (4) :951-957.

引证文献1

二级引证文献1

临床和实验医学杂志
2006年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部